Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestMortgage LoansNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - DoubtfulReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Cash & Equivalents (2023 - 2025)

WORK Medical Technology filings provide 3 years of Cash & Equivalents readings, the most recent being $4.1 million for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 37.65% to $4.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.1 million, a 37.65% decrease, with the full-year FY2025 number at $4.1 million, down 37.65% from a year prior.
  • Cash & Equivalents hit $4.1 million in Q3 2025 for WORK Medical Technology, up from $2.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $6.6 million in Q3 2024 to a low of $1.6 million in Q3 2023.
  • Median Cash & Equivalents over the past 3 years was $3.0 million (2025), compared with a mean of $3.6 million.
  • Biggest five-year swings in Cash & Equivalents: soared 310.85% in 2024 and later crashed 37.65% in 2025.
  • WORK Medical Technology's Cash & Equivalents stood at $1.6 million in 2023, then soared by 310.85% to $6.6 million in 2024, then plummeted by 37.65% to $4.1 million in 2025.
  • The last three reported values for Cash & Equivalents were $4.1 million (Q3 2025), $2.0 million (Q1 2025), and $6.6 million (Q3 2024) per Business Quant data.